Senior Downstream Product Manager

bostonscientific•Maple Grove, MN

27d•$99,100 - $188,300•Hybrid

About The Position

The Senior Downstream Product Manager for Eluvia plays a critical role in driving the commercial franchise success of Boston Scientific’s drug eluting stent portfolio. This position is responsible for translating Eluvia’s robust and complex clinical and economic evidence into clear, compelling messaging and commercial tools that resonate with customers and highlight’s the brand’s differentiated value in the market. This role leads downstream marketing execution and competitive strategy, identifying opportunities to strengthen Eluvia’s positioning and drive share growth. The individual will collaborate cross-functionally with Medical Affairs, Health Economics, and Marketing Activation teams, as well as partner closely with the sales organization and key physicians to ensure cohesive, impactful communication across all customer touchpoints. The ideal candidate is a strategic, insightful marketer who brings curiosity, collaboration, and creativity to their work. This individual will play a key role in shaping how Eluvia’s story is told, connecting data and value to elevate the franchise and advance Boston Scientific’s mission to improve patient outcomes around the world. Work Mode: At Boston Scientific, we value collaboration and synergy. This role follows a hybrid work model requiring employees to be in our local office at least three days per week.

Requirements

Bachelor’s degree in marketing, engineering, or healthcare
5+ years prior product management experience (product launch/commercialization)
Experience in developing and implementing strategic marketing plans, campaigns and initiatives through core team leadership
Proven ability to influence drive alignment across diverse teams to achieve consensus and execution of strategic initiatives
Excellent communication skills (verbal and written) and interpersonal skills
Project management skills and experience
Strong analytical, strategic planning and financial analysis skills
Experience with building strong physician relationships
Ability to travel up to 30% of the time, to include international travel.

Nice To Haves

Master’s/MBA preferred
Experience specifically in peripheral vascular med device marketing

Responsibilities

Transform complex evidence into impact. Translate Eluvia’s clinical and economic data into clear, compelling messaging, tools, and training that drive customer understanding and preference.
Lead downstream marketing execution. Develop and deliver campaigns, materials, and programs that reinforce Eluvia’s differentiated value and accelerated adoption across global and regional markets.
Drive competitive strategy and perception change. Identify and address barriers to adoption by shaping how customers perceive Eluvia versus alternatives, shifting long-held beliefs and behaviors in a mature, competitive market.
Own the economic story. Partner closely with Health Economics and Medical Affairs to simplify and communicate a value proposition that links outcomes, cost, and long-term clinical benefit.
Enable sales excellence. Equip the field teams with compelling tools, training, and messaging frameworks to elevate customer conversations and overcome complex objections.
Collaborate cross-functionally. Work closely with clinical, marketing strategy, brand activation, and medical affairs to ensure alignment between data, story, and execution.
Monitor and respond to market dynamics. Track competitor activity, evolving guidelines and market trends to inform strategy and identify new opportunities for growth.
Champion brand consistency. Ensure that all downstream content and communications reflect Eluvia’s value, clinical leadership, and strategic positioning.
Measure impact. Evaluate the effectiveness of programs, campaigns, and tools through data-driven metrics and refine approaches for continuous improvement.
Be a steward of performance. Manage this high-profile product with accountability for business results, acting as a key driver of revenue growth and strategic execution within the Drug Eluting Therapies portfolio.